Cited by 7,439Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionEconomic and Financial Impacts of Cancer

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Cancer Statistics, 2007

Open access

Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M. J.·2007·CA: A Cancer Journal for Clinicians

DOI 10.3322/canjclin.57.1.43

Open this paper in CoChat — free account

Abstract

Each year, the American Cancer Society (ACS) estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. This report considers incidence data through 2003 and mortality data through 2004. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,444,920 new cancer cases and 559,650 deaths for cancers are projected to occur in the United States in 2007. Notable trends in cancer incidence and mortality rates include stabilization of the age-standardized, delay-adjusted incidence rates for all cancers combined in men from 1995 through 2003; a continuing increase in the incidence rate by 0.3% per year in women; and a 13.6% total decrease in age-standardized cancer death rates among men and women combined between 1991 and 2004. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. While the absolute number of cancer deaths decreased for the second consecutive year in the United States (by more than 3,000 from 2003 to 2004) and…

Integrity signals

Registry

Crossref · 10.3322/canjclin.57.1.43

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V. E., Singh, G. K., Cardinez, C. J., Ghafoor, A., & Thun, M. J. (2004) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,796
Self-citation
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,141
Self-citation
Cancer Statistics for African Americans
Ghafoor, A., Jemal, A., Cokkinides, V. E., Cardinez, C. J., Murray, T., Samuels, A., & Thun, M. J. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.326 · Cited by 549
Self-citation
Cancer Survival Among US Whites and Minorities
Clegg, L. X., Li, F. P., Hankey, B. F., Chu, K. C., & Edwards, B. K. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.17.1985 · Cited by 535
Survival of Blacks and Whites After a Cancer Diagnosis
Bach, P. B. (2002) · JAMA · doi:10.1001/jama.287.16.2106 · Cited by 514
Trends in Breast Cancer by Race and Ethnicity
Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V. E., Smith, R. A., & Thun, M. J. (2003) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.6.342 · Cited by 450
Self-citation
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.20.1537 · Cited by 282
A New Method of Estimating United States and State-level Cancer Incidence Counts for the Current Calendar Year
Pickle, L. W., Hao, Y., Jemal, A., Zou, Z., Tiwari, R. C., Ward, E., Hachey, M., Howe, H. L., & Feuer, E. J. (2007) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.30 · Cited by 114
Self-citation
A New Method of Predicting US and State-Level Cancer Mortality Counts for the Current Calendar Year
Tiwari, R. C., Ghosh, K., Jemal, A., Hachey, M., Ward, E., Thun, M. J., & Feuer, E. J. (2004) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.30 · Cited by 67
Self-citation

Show all 10 references

Sorted by citations

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
Phaniendra, A., Jestadi, D. B., & Periyasamy, L. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0446-0 · Cited by 2,886
Cancer is a preventable disease that requires major lifestyle changes
Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung, B., & Aggarwal, B. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9661-9 · Cited by 2,632
Head and neck cancer
Argiris, A. E., Karamouzis, M. V., Raben, D., & Ferris, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60728-x · Cited by 2,287
Improved survival in multiple myeloma and the impact of novel therapies
Kumar, S. K., Rajkumar, S. V., Dispenzieri, A. A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Zeldenrust, S. R., Dingli, D., Russell, S. J., Lust, J. A., et al. (2007) · Blood · doi:10.1182/blood-2007-10-116129 · Cited by 2,241
Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
Cohen, S. J., Punt, C. J. A., Iannotti, N. O., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E. P., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,876
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,705
Magnetic nanoparticles for drug delivery
Arruebo, M., Fernández‐Pacheco, R., Ibarra, M. R., & Santamarı́a, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,646
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. �., Au, G. K. �., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,591
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
Kim, E. S., Hirsh, V., Mok, T. S. K., Socinski, M. A., Gervais, R., Wu, Y.-L. L. C., Li, L.-Y., Watkins, C. L., Sellers, M. V., Lowe, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61758-4 · Cited by 1,241
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,134
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
Margulis, V., Shariat, S. F., Matin, S. F., Kamat, A. M., Zigeuner, R. E., Kikuchi, E., Lotan, Y., Weizer, A. Z., Raman, J. D., & Wood, C. G. (2009) · Cancer · doi:10.1002/cncr.24135 · Cited by 1,133
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Sturgeon, C. M., Duffy, M. J., Stenman, U., Lilja, H. G., Brünner, N., Chan, D. W., Babaian, R. J., Bast, R. C., Dowell, B. L., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,140
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Escudier, B. J., Eisen, T. G., Stadler, W. M., Szczylik, C. A., Oudard, S. M., Staehler, M. D., Négrier, S., Chevreau, C., Desai, A. A., Rolland, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.5511 · Cited by 1,087
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Iacobuzio-Donahue, C. A., Fu, B., Yachida, S., Luo, M., Abe, H., Henderson, C. M., Vilardell, F., Wang, Z., Keller, J. W., Banerjee, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7188 · Cited by 1,081
Microbial drug discovery: 80 years of progress
Demain, A. L., & Sánchez, S. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2008.16 · Cited by 1,004
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Koivunen, J. P., Mermel, C. H., Zejnullahu, K., Murphy, C., Lifshits, E., Tisch, A. H., Choi, H. G., Kim, J., Chiang, D. Y., Thomas, R. K., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0168 · Cited by 1,001
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 981
Immunosenescence: molecular mechanisms and diseases
Liu, Z., Liang, Q., Ren, Y., Guo, C., Ge, X., Wang, L., Cheng, Q., Luo, P., Zhang, Y., & Han, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01451-2 · Cited by 1,082
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
Wadas, T. J., Wong, E. H., Weisman, G. R., & Anderson, C. J. (2010) · Chemical Reviews · doi:10.1021/cr900325h · Cited by 965
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Lilja, H. G., Ulmert, D., & Vickers, A. J. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2351 · Cited by 924
Prevalence of Unsuspected Pancreatic Cysts on MDCT
Laffan, T. A., Horton, K. M., Klein, A. P., Berlanstein, B. P., Siegelman, S. S., Kawamoto, S., Johnson, P. T., Fishman, E. K., & Hruban, R. H. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3340 · Cited by 882
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P. J., Cohen, P. A., Golshayan, A., Rayman, P. A., Wood, L. S., García, J. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 861
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
Jazdzewski, K., Murray, E. L., Franssila, K., Jarzab, B., Schoenberg, D. R., & de la Chapelle, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802682105 · Cited by 842
The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
Youlden, D. R., Cramb, S. M., & Baade, P. D. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818020eb · Cited by 817
TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck
Poeta, M. L., Manola, J. B., Goldwasser, M. A., Forastiere, A. A., Benoit, N. E., Califano, J. A., Ridge, J. A., Goodwin, J. W., Kenady, D. E., Saunders, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073770 · Cited by 818
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody
Benson, D. M., Bakan, C. E., Mishra, A., Hofmeister, C. C., Efebera, Y., Becknell, B., Baiocchi, R. A., Zhang, J., Yu, J., Smith, M. K., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271874 · Cited by 807
Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging
Mariani, A., Dowdy, S. C., Cliby, W. A., Gostout, B. S., Jones, M. B., Wilson, T. O., & Podratz, K. C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.023 · Cited by 806
Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
Wapnir, I., Dignam, J. J., Fisher, B., Mamounas, E., Anderson, S., Julian, T. B., Land, S. R., Margolese, R. G., Swain, S. M., Costantino, J. P., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr027 · Cited by 783
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Kulasingam, V., & Diamandis, E. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1187 · Cited by 769
Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
Joaquim Bellmunt, B., Théodore, C., Demkov, T., Komyakov, B. K., Sengeløv, L., Daugaard, G., Caty, A., Carles, J., Jagiełło-Gruszfeld, A., Karyakin, O., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5534 · Cited by 766
Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer
Cannistra, S. A., Matulonis, U. A., Penson, R. T., Hambleton, J., Dupont, J., Mackey, H. M., Douglas, J., Burger, R. A., Armstrong, D. K., Wenham, R. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0782 · Cited by 760
Trends in head and neck cancer incidence in relation to smoking prevalence
Sturgis, E. M., & Cinciripini, P. M. (2007) · Cancer · doi:10.1002/cncr.22963 · Cited by 754
Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis
Ragin, C. C. R., & Taioli, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22851 · Cited by 743
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Cohen, E. E. W., Bell, R. B., Bifulco, C. B., Burtness, B. A., Gillison, M. L., Harrington, K. J., Le, Q., Lee, N. Y., Leidner, R. S., Lewis, R. L., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0662-5 · Cited by 733
The EML4‐ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild‐type EGFR and KRAS
Wong, D. W., Leung, E. L., So, K. K., Tam, I. Y. S., Sihoe, A. D., Cheng, L., Ho, K., Au, J. S. K., Chung, L., & Wong, M. P. (2009) · Cancer · doi:10.1002/cncr.24181 · Cited by 726
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 720
Apoptosis and cancer: mutations within caspase genes
Ghavami, S., Hashemi, M. M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., Bus, C., Kadkhoda, K., Wiecheć, E., Halayko, A. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066944 · Cited by 721
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma
Daud, A. I., DeConti, R. C., Andrews, S., Urbas, P., Riker, A. I., Sondak, V. K., Munster, P. N., Sullivan, D. M., Ugen, K. E., Messina, J. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6794 · Cited by 701
Ovarian Cancer
Cho, K. R., & Shih, I. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092246 · Cited by 694
Phase II Trial of Sorafenib in Advanced Thyroid Cancer
Abramson, V. G., Troxel, A. B., Nellore, A., Puttaswamy, K., Redlinger, M., Ransone, K., Mandel, S. J., Flaherty, K. T., Loevner, L. A., O'Dwyer, P. J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3279 · Cited by 674
History and principles of patient navigation
Freeman, H. P., & Rodriguez, R. L. (2011) · Cancer · doi:10.1002/cncr.26262 · Cited by 666
Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: In vitro and in vivo evaluations
Kim, M. S., Haney, M. J., Zhao, Y., Yuan, D., Deygen, I., Klyachko, N. L., Kabanov, A. V., & Batrakova, E. V. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.09.011 · Cited by 663
Physical Education and Physical Activity: Results From the School Health Policies and Programs Study 2006
Lee, S. M., Burgeson, C. R., Fulton, J. E., & Spain, C. G. (2007) · Journal of School Health · doi:10.1111/j.1746-1561.2007.00229.x · Cited by 653
Most Pancreatic Cancer Resections are R1 Resections
Esposito, I., Kleeff, J. H., Bergmann, F., Reiser, C., Herpel, E., Frieß, H., Schirmacher, P., & Büchler, M. W. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9839-8 · Cited by 643
Is Breast Cancer the Same Disease in Asian and Western Countries?
Leong, S. P. L., Shen, Z., Liu, T., Agarwal, G., Tajima, T., Paik, N. S., Sandelin, K., Derossis, A. M., Cody, H. S., & Foulkes, W. D. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0683-1 · Cited by 633
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621
Medicinal Plants and Cancer Chemoprevention
Desai, A., Qazi, G., Ganju, R., El-Tamer, M., Singh, J., Saxena, A., Bedi, Y. S., Taneja, S., & Bhat, H. (2008) · Current Drug Metabolism · doi:10.2174/138920008785821657 · Cited by 627
Pancreatic cancer: A review of epidemiology, trend, and risk factors
Hu, J.-X., Zhao, C., Chen, W.-B., Liu, Q., Li, Q.-W., Lin, Y., & Gao, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i27.4298 · Cited by 643
Patient navigation: State of the art or is it science?
Wells, K. J., Battaglia, T. A., Dudley, D. J., Garcia, R., Greene, A. L., Calhoun, E. A., Mandelblatt, J. S., Paskett, E. D., & Raich, P. C. (2008) · Cancer · doi:10.1002/cncr.23815 · Cited by 572
Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)
Ballester, M., Dubernard, G., Lecuru, F. R., Heitz, D., Mathevet, P., Marret, H., Querleu, D., Golfier, F., Leblanc, É., Rouzier, R., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70070-5 · Cited by 572
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Pannala, R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70337-1 · Cited by 577
Expression of Yes-associated protein in common solid tumors
Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., Montgomery, E. A., & Anders, R. A. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.04.012 · Cited by 560
Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
García, A. A., Hirte, H. W., Fleming, G. F., Yang, D., Tsao-Wei, D. D., Roman, L. D., Groshen, S. G., Swenson, S. D., Markland, F. S., Gandara, D. R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1939 · Cited by 548
The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth
Schmidt, L. H., Spieker, T., Koschmieder, S., Humberg, J., Jungen, D., Bulk, E., Hascher, A., Wittmer, D., Marra, A., Hillejan, L., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182307eac · Cited by 550
Metastatic tumours to the oral cavity – Pathogenesis and analysis of 673 cases
Hirshberg, A., Shnaiderman-Shapiro, A., Kaplan, I., & Berger, R. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.09.012 · Cited by 534
Guideline implementation for breast healthcare in low-income and middle-income countries
Anderson, B. O., Yip, C. H., Smith, R. A., Shyyan, R., Sener, S. F., Eniu, A. E., Carlson, R. W., Azavedo, E., & Harford, J. B. (2008) · Cancer · doi:10.1002/cncr.23844 · Cited by 534
Cholangiocarcinoma: lessons from Thailand
Sripa, B., & Pairojkul, C. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282fbf9b3 · Cited by 532
Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
Riker, A. I., Enkemann, S. A., Fodstad, Ø., Liu, S., Ren, S., Morris, C. G., Xi, Y., Howell, P., Metge, B. J., Samant, R. S., et al. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-13 · Cited by 525
Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta‐analysis
Liang, P. S., Chen, T., & Giovannucci, E. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.24191 · Cited by 554
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
Mauri, D., Polyzos, N. P., Salanti, G., Pavlidis, N. A., & Ioannidis, J. P. A. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn414 · Cited by 528
A Comprehensive Review of Apples and Apple Components and Their Relationship to Human Health
Hyson, D. A. (2011) · Advances in Nutrition · doi:10.3945/an.111.000513 · Cited by 523
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Meyskens, F. L., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E. T., Kelloff, G. J., Lawson, M. J., Kidao, J., McCracken, J., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0042 · Cited by 518
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women
Gillison, M. L., Chaturvedi, A. K., & Lowy, D. R. (2008) · Cancer · doi:10.1002/cncr.23764 · Cited by 530
Excise, Ablate or Observe: The Small Renal Mass Dilemma—A Meta-Analysis and Review
Kunkle, D. A., Egleston, B. L., & Uzzo, R. G. (2008) · The Journal of Urology · doi:10.1016/j.juro.2007.11.047 · Cited by 516
Prostate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, O. A., Stanford, J. L., Zietman, A. L., et al. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.07.093 · Cited by 503
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
Cohen, S. J., Punt, C. J. A., Iannotti, N. O., Saidman, B. H., Sabbath, K. D., Gabrail, N., Picus, J., Morse, M. A., Mitchell, E. P., Miller, M. C., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn786 · Cited by 513
Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
Wallace, T. A., Prueitt, R. L., Yi, M., Howe, T. M., Gillespie, J. W., Yfantis, H. G., Stephens, R. M., Caporaso, N. E., Loffredo, C. A., & Ambs, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2608 · Cited by 512
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
Pai, S. I., & Westra, W. H. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092158 · Cited by 532
Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention
Nagini, S. (2012) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v4.i7.156 · Cited by 509
Systemic Treatment of Colorectal Cancer
Wolpin, B. M., & Mayer, R. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.098 · Cited by 526
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 506
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment
Hallek, M. J. (2019) · American Journal of Hematology · doi:10.1002/ajh.25595 · Cited by 523
YM155, a Novel Small-Molecule Survivin Suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor Xenografts
Nakahara, T., Takeuchi, M., Kinoyama, I., Minematsu, T., Shirasuna, K., Matsuhisa, A., Kita, A., Tominaga, F., Yamanaka, K., Kudoh, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1343 · Cited by 499
Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Spector, N. L., & Blackwell, K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1507 · Cited by 506
Unravelling the biology of SCLC: implications for therapy
Sabari, J. K., Lok, B. H., Laird, J. H., Poirier, J. T., & Rudin, C. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.71 · Cited by 493
Physical Activity and Survival after Diagnosis of Invasive Breast Cancer
Holick, C. N., Newcomb, P. A., Trentham‐Dietz, A., Titus-Ernstoff, L. T., Bersch, A. J., Stampfer, M. J., Baron, J. A., Egan, K. M., & Willett, W. C. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0771 · Cited by 501
Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
Callahan, M., Crum, C., Medeiros, F., Kindelberger, D., Elvin, J., Garber, J., Feltmate, C., Berkowitz, R., & Muto, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2622 · Cited by 518
A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer
Huang, C., Ju, D., Chang, C.-F., Reddy, P. M., & Velmurugan, B. K. (2017) · Biomedicine · doi:10.1051/bmdcn/2017070423 · Cited by 483
FCGR2A and FCGR3A Polymorphisms Associated With Clinical Outcome of Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Cancer Patients Treated With Single-Agent Cetuximab
Zhang, W., Gordon, M. A., Schultheis, A. M., Yang, D., Nagashima, F., Azuma, M., Chang, H.-M., Borucka, E., Lurje, G., Sherrod, A. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8021 · Cited by 487
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Katz, M. H. G., Wang, H., Fleming, J. B., Sun, C. C., Hwang, R. F., Wolff, R. A., Varadhachary, G. A., Abbruzzese, J. L., Crane, C. H., Krishnan, S., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0295-2 · Cited by 481
UK guidelines for the management of soft tissue sarcomas
Dangoor, A., Seddon, B. M., Gerrand, C., Grimer, R. J., Whelan, J. S., & Judson, I. R. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0060-4 · Cited by 479
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
Weichert, W., Roske, A.-E., Gekeler, V., Beckers, T. L., Stephan, C., Jung, K., Fritzsche, F., Niesporek, S., Denkert, C., Dietel, M., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604199 · Cited by 478
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Shi, X.-B., Xue, L., Yang, J., Ma, A.-H., Zhao, J., Xu, M., Tepper, C. G., Evans, C. P., Kung, H.-J., & deVere White, R. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706641104 · Cited by 378
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
Daniel, V. C., Marchionni, L., Hierman, J. S., Rhodes, J. T., Devereux, W. L., Rudin, C. M., Yung, R., Parmigiani, G., Dorsch, M., Peacock, C. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4210 · Cited by 469
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Shin, D. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2824 · Cited by 467
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
Schnelldorfer, T., Ware, A. L., Sarr, M. G., Smyrk, T. C., Zhang, L., Qin, R., Gullerud, R. E., Donohue, J. H., Nagorney, D. M., & Farnell, M. B. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181613142 · Cited by 457
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
Chan, J. K., Teoh, D. K., Hu, J. M., Shin, J. Y., Osann, K., & Kapp, D. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.02.006 · Cited by 453
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Haese, A., TAILLE, A. D. L., Poppel, H. V., Marberger, M., Stenzl, A., Mulders, P., Huland, H., Abbou, C.-C. C., Mesut Remzi, A., Tinzl, M., et al. (2008) · European Urology · doi:10.1016/j.eururo.2008.06.071 · Cited by 453
Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment
Cooperberg, M. R., Broering, J. M., Kantoff, P. W., & Carroll, P. R. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.135 · Cited by 442
Physician Referral for Fertility Preservation in Oncology Patients: A National Study of Practice Behaviors
Quinn, G. P., Vadaparampil, S. T., Lee, J., Jacobsen, P. B., Bepler, G., Lancaster, J. M., Keefe, D. L., & Albrecht, T. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0250 · Cited by 441
A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
Bonome, T., Levine, D. A., Shih, J. H., Randonovich, M., Pise-Masison, C. A., Bogomolniy, F., Ozbun, L. L., Brady, J. N., Barrett, J. C., Boyd, J. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6595 · Cited by 438
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0234 · Cited by 456
Guidelines for the Management of Soft Tissue Sarcomas
Grimer, R. J., Judson, I. R., Peake, D., & Seddon, B. M. (2010) · Sarcoma · doi:10.1155/2010/506182 · Cited by 445
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
Li, J., Huang, H., Sun, L., Yang, M., Pan, C., Chen, W., Wu, D., Lin, Z., Zeng, C., Yao, Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3053 · Cited by 431
Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study
Kromrey, M., Bülow, R., Hübner, J., Paperlein, C., Lerch, M. M., Ittermann, T., Völzke, H., Mayerle, J. V., & Kühn, J. (2017) · Gut · doi:10.1136/gutjnl-2016-313127 · Cited by 433
American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer
Wong, S. L., Mangu, P. B., Choti, M. A., Crocenzi, T. S., Dodd, G. D., Dorfman, G. S., Eng, C., Fong, Y., Giusti, A. F., Lu, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4450 · Cited by 428

Authors: Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J.
Affiliations: American Cancer Society (US)
Centers for Disease Control and Prevention (US)
ORCID: Jemal, A.
Siegel, R.
Ward, E.
Xu, J.
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2007-01-01
Volume: 57
Issue: 1
Pages: 43-66
ISSN: 0007-9235 (ISSN-L)
DOI: 10.3322/canjclin.57.1.43
OpenAlex: W1965734230
Cited by: 7,439
References: 10
Citations by year: 2026: 18 · 2025: 34 · 2024: 74 · 2023: 104 · 2022: 93 · 2021: 125 · 2020: 135 · 2019: 100 · 2018: 117 · 2017: 182 · 2016: 196 · 2015: 217 · 2014: 333 · 2013: 334 · 2012: 419
FWCI: 749.63
Type: journal article
Language: en
Open access: gold
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3165 d)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords: cancer incidence, cancer mortality, cancer survival, cancer projections, age-standardized incidence rate, sex differences in cancer, racial and ethnic disparities, geographic variation in cancer, cancer control
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Cause of Death, Child, Child, Preschool, Female, Geography, Humans, Infant, Infant, Newborn, Male, Middle Aged, Neoplasms, Population Surveillance, United States, Models, Statistical, Incidence, Survival Analysis, Age Distribution, Sex Distribution, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer Statistics, 2007

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks